Virtual Posters & Abstracts

Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2022 Lymphoma, Leukemia & Myeloma Congress. 

  • Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000+ attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies
  • Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network
  • Receive Accolades. Each year the Congress Chairs recognize the “Best Of” submitted abstracts. Winning abstracts receive free congress registration

Accepted abstracts will be published in the American Journal of Hematology and shared with attendees as digital posters accessible online. Only abstracts received by the submission deadline will be published.

Please upload your poster by October 11th, 2022. Click here for details on how to submit your ePoster: 

Abstracts will be accepted in the following categories: Non-Malignant Hematology DiseasesAcute Leukemia & Myeloproliferative/Myelodysplastic Diseases, Multiple Myeloma, Chronic Lymphocytic Leukemia or Lymphoma. Please indicate which category applies to your abstract by checking the appropriate box in the online submission system.


    Abstract Categories

    Acute Leukemia & Myeloproliferative/Myelodysplatic Diseases  
    A1. Clinical Trials
    A2. Procedures and Diagnostics
    A3. Epidemiology and Outcomes Research
    A4. Clinical Case Reports
    A5. Trials in Progress

    Multiple Myeloma
    M1. Clinical Trials
    M2. Procedures and Diagnostics
    M3. Epidemiology and Outcomes Research
    M4. Clinical Case Reports
    M5. Trials in Progress

    Chronic Lymphocytic Leukemia 
    C1. Clinical Trials
    C2. Procedures and Diagnostics
    C3. Epidemiology and Outcomes Research
    C4. Clinical Case Reports
    C5. Trials in Progress

    L1. Clinical Trials
    L2. Procedures and Diagnostics
    L3. Epidemiology and Outcomes Research
    L4. Clinical Case Reports
    L5. Trials in Progress

    Non-Malignant Hematology Diseases

    N1. Clinical Trials
    N2. Procedures and Diagnostics
    N3. Epidemiology and Outcomes Research
    N4. Clinical Case Reports
    N5. Trials in Progress